Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 4, 1998, Pages 1047-1050

  Karagas, Margaret R ^a   Tosteson, Tor D ^a   Blum, Joel ^b   Morris, J Steven ^c   Baron, John A ^a   Klaue, Bjoern ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Lamont Doherty Earth Observatory   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Arsenic; Basal cell skin cancer; Bladder cancer; Case control studies; Epidemiologic studies; Exposure assessment; Heavy metals; Nonmelanoma skin cancer; Squamous cell skin cancer

Indexed keywords

ARSENIC; DRINKING WATER;

BASAL CELL CARCINOMA; BLADDER CANCER; CASE CONTROL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOMA; UNITED STATES; WATER CONTAMINATION;

EID: 0031656631     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s41047     Document Type: Conference Paper

References (23)

1. Azcue JM, Nriagu JO. Arsenic: historical perspectives. In: Arsenic in the Environment. Vol 26 (Nriagu J, ed). New York:John Wiley & Sons, 1994;1-15.
2. IARC. Arsenic and Arsenic Compounds (group 1). In: Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Supplement 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42. Lyon:International Agency for Research on Cancer, 1987;100-106.
3. Franseen CC, Taylor GW. Arsenical keratoses and carcinomas. Am J Cancer 22:287-307 (1934).
4. Tseng WP, Chur HM, How SW. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40:453-463 (1968).
5. Brown K, Boyle K, Chen C, Gibb H. A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Anal 9:519-528 (1989).
6. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT. Cancer risks from arsenic in drinking water. Environ Health Perspect 97:259-267 (1992).
7. Bates MN, Smith AH, Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141:523-530 (1995).
8. Morton W, Starr G, Pohl D. Skin cancer and water arsenic in Lane County, Oregon. Cancer 37:2523-2532 (1976).
9. Berg J, Burbank F. Correlations between carcinogenic trace metals in water supplies and cancer mortality. Ann NY Acad Sci 199:249-261 (1972).
10. U.S. Department of Commerce, Economics and Statistics Administration, Bureau of the Census. 1990 Census of the Population and Housing. Washington:U.S. Government Printing Office, 1992.
11. U.S. Congress, Senate Committee on Environmental and Public Works. Safe Drinking Water Act of 1974. PL104-182. Environ Reporter 71:5601-5654 (1995).
12. Armstrong BK, Kricker A. Skin cancer. Dermatol Clin 13:583-594 (1995).
13. Yeh S, How SW, Lin CS. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer 21:312-339 (1968).
14. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia:Lippincott-Raven, 1998.
15. Morris Brown L, Hoar Zahm S, Hoover RN, Fraumeni JF. High bladder cancer mortality in rural New England (United States): an etiologic study. Cancer Causes Control 6:361-368 (1995).
16. Hsueh Y, Chiou H, Huang Y, Lue L, Chen G, Chen C. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 6:589-596 (1997).
17. Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ, Willett WC, Hunter DJ. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493-497 (1993). [Published erratum appears in Cancer Epidemiol Biomarkers Prev 3(6):523 (1994)].
18. Karagas MR, Morris JS, Weiss JE, Spate V, Baskett C, Greenberg ER. Toenail samples as an indicator of drinking water arsenic exposure. Cancer Epidemiol Biomarkers Prev 5:849-852 (1996).
19. Chiou H, Hsueh Y, Hsieh L, Hsu L, Hsu Y, Hsieh F, Wei M, Chen H, Yan H, Leu L, et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res 386:197-207 (1997).
20. Cheng TP, Morris JS, Koirtyohann SR, Spate VL, Baskett CJ. Study of the correlation of trace elements in carpenter's toenails. J Radioanal Nucl Chem 195:31-42 (1995).
21. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Arsenic. Atlanta, GA:U.S. Department of Health and Human Services, 1993.
22. Montassar A, Golightly DW. ICPs in Analytical Atomic Spectrometry. Weinheim:VCH Verlagsgesellschaft mbH, 1992.
23. Corbeil RR, Searle SR. Restricted maximum likelihood (REML) estimation of variance components in the mixed model. Technometrics 18:31-38 (1976).